“These findings should reassure both clinicians and patients that mt-sDNA testing can be performed safely without stopping anticoagulant or antiplatelet therapy,” Garg told Healio. “From a ...

The primary safety outcome was the rate of sICH according to the European Cooperative Acute Stroke Study criteria. Results: Out of 4’444 patients, 1’308 were matched successfully: 480 without APT, 764 ...

Reperfusion therapies are recommended for acute ischemic stroke but are often inaccessible due to time constraints and limited access to endovascular care. As a result, antiplatelet therapy, ...

Background Ticagrelor, a P2Y12 inhibitor, offers a rapid onset and consistent platelet inhibition, making it a viable alternative for dual antiplatelet therapy (DAPT). The optimal ticagrelor dose for ...

5 The Improving Reperfusion Strategies in Ischemic Stroke Collaborators (IRIS) conducted an urgent meta-analysis of six RCTs and concluded that bridging therapy is the preferred option for acute ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...